Latest Insurance News

Findi Limited is applying for two key licences from the Reserve Bank of India to expand its digital payments footprint, aiming to bridge the gap between cash and digital economies across India.

Helia Group reveals ING Bank Australia will not renew its Lenders Mortgage Insurance contract beyond June 2026, prompting a strategic business review amid evolving market dynamics.

IAG has revised its FY25 financial guidance upward, citing a $200 million reduction in expected natural perils costs, including significant claims from recent NSW floods. This update lifts profit and margin forecasts amid steady premium growth.

Noumi Limited has received Victorian Supreme Court approval for its $43 million class action settlement, closing a significant chapter tied to past financial restatements. The company’s insurer will cover its $11.56 million contribution, while legal costs will impact FY25 results.

New World Resources has secured a crucial environmental permit for its Antler Copper Project in Arizona, accelerating its path toward construction. This milestone reflects strong state support and positions the company to begin building later in 2025.

Treasury Wine Estates has secured Supreme Court approval for a $65 million settlement of a consolidated shareholder class action, allowing the company to focus on its strategic goals without admitting liability.

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.

Fletcher Building and its joint venture partner have resolved a longstanding dispute with NZTA over COVID-19 and weather-related delays on the Puhoi to Warkworth motorway, resulting in a $16.4 million EBIT loss in FY25 but securing $56 million in cash proceeds.

Opyl Limited’s AI platform TrialKey has partnered with UK insurer Innovatrix to launch a pioneering parametric insurance product that protects biotech firms from the financial risks of clinical trial failures.

Emyria has landed a multi-year funding deal with Medibank to support its Empax PTSD program at Perth Clinic, marking a first for private insurer-backed psychotherapy in Australia. The company also announces a $4 million capital raise to fuel national expansion.

Dubber Corporation has initiated court proceedings against its former auditors following a $26.6 million misappropriation uncovered in FY24, aiming to restore financial stability by year-end.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.